Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug Development
Georgi I. Kapitanov(Certara (United States)), Piet H. van der Graaf(Pfizer (United Kingdom)), Mirjam N. Trame(AVEO Oncology (United States)), Anna Kondic(Merck & Co., Inc., Rahway, NJ, USA (United States)), Amita Joshi(Acentech (United States)), Jin Y. Jin(Jiangxi Normal University), Kapil Gadkar(Sea Turtle Conservancy), Justin Earp(United States Food and Drug Administration), Blerta Shtylla(Pfizer (United States)), Cynthia J. Musante(University of North Carolina at Chapel Hill)
Cited by 3
Related Papers
Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates
|Science Translational Medicine|2014|373
Addressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain Barrier
|Science Translational Medicine|2013|267
A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models
|Nature Neuroscience|2023|227
Pembrolizumab Exposure–Response Assessments Challenged by Association of Cancer Cachexia and Catabolic Clearance
|Clinical Cancer Research|2018|216
FDA Approval Summary: Vemurafenib for Treatment of Unresectable or Metastatic Melanoma with the BRAFV600E Mutation
|Clinical Cancer Research|2014|215